Understanding knowledge and attitudes of health care professionals (HCPs) towards adverse drug reaction (ADR) reporting can inform educational interventions promoting ADR reporting.
OBJECTIVE:
To explore knowledge, attitudes, practice, and barriers of local HCPs towards ADR reporting.
METHODS:
Focus groups involving HCPs from different settings were organized to help develop a questionnaire. The questionnaire was validated and disseminated to pharmacists, physicians, dentists and nurses practicing in Malta. A review of ADR reports reported in Malta from 2004 to 2021 was carried out to contextualise questionnaire findings.
RESULTS:
Overall, HCPs (n = 374) had good knowledge on pharmacovigilance and a positive attitude towards ADR reporting however nurses were found to be less knowledgeable than physicians, dentists, and pharmacists. The main barrier for not reporting ADRs was difficulty to understand whether an adverse event occurred (n = 187). A total of 2581 ADR reports were reported in Malta. Among HCPs, physicians and dentists reported most ADRs (1060 reports), followed by pharmacists (307 reports) and nurses (257 reports).
CONCLUSION:
Further ADR educational and promotional efforts are needed to increase awareness on the importance of quality ADR reporting and increase the number of ADR reports reported by local HCPs.
SendekieAKKasahunAELimenhLWDagnawADBelachewEA. Clinical and economic impact of adverse drug reactions in hospitalised patients: Prospective matched nested case-control study in Ethiopia. BMJ Open. 2023;13(6):e073777.
2.
AyalewMBTegegnHGAbdelaOA. Drug related hospital admissions; a systematic review of the recent literatures. Bull Emerg Trauma. 2019;7(4):339–46.
3.
KhalilHHuangC. Adverse drug reactions in primary care: A scoping review. BMC Health Serv Res. 2020;20(1):5.
4.
FormicaDSultanaJCutroneoPMLucchesiSAngelicaRCrisafulliSThe economic burden of preventable adverse drug reactions: A systematic review of observational studies. Expert Opin Drug Saf. 2018;17(7):681–95.
5.
PerryLTBhasaleAFabbriALexchinJPuilLJoarderMA descriptive analysis of medicines safety advisories issued by national medicines regulators in Australia, Canada, the United Kingdom and the United States - 2007 to 2016. Pharmacoepidemiol Drug Saf. 2020;29(9):1054–63.
6.
ZuccarelliMMicallefBButlerDSerracino-InglottABorgJJ. Improving the data quality of spontaneous ADR reports: A practical example from Malta. Expert Opin Drug Saf. 2022;21(2):253–68.
7.
HailuADMohammedSA. Adverse drug reaction reporting in ethiopia: Systematic review. Biomed Res Int. 2020;2020:8569314.
8.
DesaiM. Pharmacovigilance and spontaneous adverse drug reaction reporting: Challenges and opportunities. Perspect Clin Res. 2022;13(4):177–9.
9.
TantiAMicallefBSerracino-InglottABorgJ. A review of the National pharmacovigilance system in Malta — Implementing and operating a pharmacovigilance management system. Expert Opin Drug Saf. 2017;16(1):65–76.
10.
MatlalaMFLubbeMSSteynH. The completeness of adverse drug reaction reports in South Africa: An analysis in VigiBase®. Afr J Prim Health Care Fam Med. 2023;15(1):e1–e9.
11.
García-AbeijonPCostaCTaracidoMHerdeiroMTTorreCFigueirasA. Factors associated with underreporting of adverse drug reactions by health care professionals: A systematic review update. Drug Saf. 2023;46(7):625–36. doi:10.1007/s40264-023-01302-7.
12.
KleinEBourdetteD. Postmarketing adverse drug reactions: A duty to report?Neurol Clin Pract. 2013;3(4):288–94. doi:10.1212/CPJ.0b013e3182a1b9f0.
13.
PalleriaCLeporiniCChimirriSMarrazzoGSacchettaSBrunoLLimitations and obstacles of the spontaneous adverse drugs reactions reporting: Two “challenging” case reports. J Pharmacol Pharmacother. 2013;4(Suppl 1):S66–72.
14.
Lopez-GonzalezEHerdeiroMTFigueirasA. Determinants of under-reporting of adverse drug reactions: A systematic review. Drug Saf. 2009;32(1):19–31.
15.
HughesMLWeissM. Adverse drug reaction reporting by community pharmacists—The barriers and facilitators. Pharmacoepidemiol Drug Saf. 2019;28(12):1552–9.
16.
HallitSHajjAShuhaiberPIskandarKRamiaESacreHMedication safety knowledge, attitude, and practice among hospital pharmacists in Lebanon. J Eval Clin Pract. 2019;25(2):323–39.
17.
ShankoHAbdelaJ. Knowledge, attitudes, and practices of health care professionals toward adverse drug reaction reporting in Hiwot Fana Specialized University Hospital, Harar, Eastern Ethiopia: A cross-sectional study. Hosp Pharm. 2018;53(3):177–87.
18.
GünerMDEkmekciPE. Healthcare professionals’ pharmacovigilance knowledge and adverse drug reaction reporting behavior and factors determining the reporting rates. J Drug Assess. 2019;8(1):13–20.
19.
Lopez-GonzalezEHerdeiroMTPiñeiro-LamasMFigueirasA. GREPHEPI group. Effect of an educational intervention to improve adverse drug reaction reporting in physicians: A cluster randomized controlled trial. Drug Saf. 2015;38(2):189–96.
20.
LeTTNguyenTTHNguyenCTranNHTranLANguyenTBFactors associated with spontaneous adverse drug reaction reporting among healthcare professionals in Vietnam. J Clin Pharm Ther. 2020;45(1):122–7.
21.
MulchandaniRKakkarAK. Reporting of adverse drug reactions in India: A review of the current scenario, obstacles and possible solutions. Int J Risk Saf Med. 2019;30(1):33–44.
22.
CheemaEAlmualemAABasudanATSalamatullahAKRadhwiSOAlsehliAS. Assessing the impact of structured education on the knowledge of hospital pharmacists about adverse drug reactions and reporting methods in Saudi Arabia: An open-label randomised controlled trial. Drugs Ther Perspect. 2019;35(6):296–300.
23.
KhaliliMMesgarpourBSharifiHDaneshvar DehnaviSHaghdoostAA. Interventions to improve adverse drug reaction reporting: A scoping review. Pharmacoepidemiol Drug Saf. 2020;29(9):965–92.
24.
The European Parliament and the Council of the European. Directive 2001/83/EC of the European parliament and of the council of 6 November 2001 on the Community code relating to medicinal products for human use. Official Journal of the European Communities. 2001;67–128.
25.
RadeckaALoughlinLFoyMde Ferraz GuimaraesMVSarinicVMDi GiustiMDEnhancing pharmacovigilance capabilities in the EU regulatory network: The SCOPE joint action. Drug Saf. 2018;41(12):1285–302.
AliMDHassanYAAhmadAAlaqelOAl-HarbiHAl-SuhaimiNM. Knowledge, practice and attitudes toward pharmacovigilance and adverse drug reactions reporting process among health care providers in Dammam, Saudi Arabia. Curr Drug Saf. 2018;13(1):21–5.
28.
HussainRHassaliMAHashmiFAkramT. Exploring healthcare professionals’ knowledge, attitude, and practices towards pharmacovigilance: A cross-sectional survey. J Pharm Policy Pract. 2021;14(1):5.
29.
AdisaROmitogunTI. Awareness, knowledge, attitude and practice of adverse drug reaction reporting among health workers and patients in selected primary healthcare centres in Ibadan, southwestern Nigeria. BMC Health Serv Res. 2019;19(1):926–9.
30.
HainesHMMeyerJCSummersRSGodmanBB. Knowledge, attitudes and practices of health care professionals towards adverse drug reaction reporting in public sector primary health care facilities in a South African district. Eur J Clin Pharmacol. 2020;76(7):991–1001.
31.
BorgJJSerracino-InglottAAl-HaddadD. A review of the national Adverse Drug Reaction (ADR) & medication errors reporting system of Malta. Malta Medical School Gazette. 2018;2(1):4–10.
International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline - Maintenance of the ICH Guideline on Clinical Safety Data Management: Data Elements for Transmission of Individual Case Safety Reports E2B(R2). 5 February 2001. Available from: https://admin.ich.org/sites/default/files/inline-files/E2B_R2_Guideline.pdf.
O’CallaghanJGriffinBTMorrisJMBerminghamM. Knowledge of adverse drug reaction reporting and the pharmacovigilance of biological medicines: A survey of healthcare professionals in Ireland. BioDrugs. 2018;32(3):267–80.
37.
De AngelisAColaceciSGiustiAVelloneEAlvaroR. Factors that condition the spontaneous reporting of adverse drug reactions among nurses: An integrative review. J Nurs Manag. 2016;24(2):151–63.
38.
De AngelisAGiustiAColaceciSVelloneEAlvaroR. Nurses’ reporting of suspect adverse drug reactions: A mixed-methods study. Ann Ist Super Sanita. 2015;51(4):277–83.
39.
AlshammariTMAlmoslemMJ. Knowledge, attitudes & practices of healthcare professionals in hospitals towards the reporting of adverse drug reactions in Saudi Arabia: A multi-centre cross sectional study. Saudi Pharm J. 2018;26(7):925–31.
40.
NisaZUZafarASherF. Assessment of knowledge, attitude and practice of adverse drug reaction reporting among healthcare professionals in secondary and tertiary hospitals in the capital of Pakistan. Saudi Pharm J. 2018;26(4):453–61.
41.
Kassa AlemuBBiruTT. Health care professionals’ knowledge, attitude, and practice towards adverse drug reaction reporting and associated factors at selected public hospitals in Northeast Ethiopia: A cross-sectional study. Biomed Res Int. 2019;2019:8690546.
42.
Mendes MarquesJIPolóniaJMFigueirasAGCosta SantosCMHerdeiroMT. Nurses’ attitudes and spontaneous adverse drug reaction reporting: A case-control study in Portugal. J Nurs Manag. 2016;24(3):409–16.
43.
LiRCurtisKVanCTabish Razi ZaidiSYeoCYArun KaliCWhy hospital-based healthcare professionals do not report adverse drug reactions: A mixed methods study using the Theoretical Domains Framework. Eur J Clin Pharmacol. 2022;78(7):1165–75.
44.
DuarteMFerreiraPSoaresMCavacoAMartinsAP. Community pharmacists’ attitudes towards adverse drug reaction reporting and their knowledge of the new pharmacovigilance legislation in the southern region of Portugal: A mixed methods study. Drugs Ther Perspect. 2015;31:316–22.
45.
YuYMLeeEKooBSJeongKHChoiKHKangLKPredictive factors of spontaneous reporting of adverse drug reactions among community pharmacists. PLoS One. 2016;11(5):e0155517.
46.
ObaraTYamaguchiTSatohMIidaYSakaiTAokiYPrevalence, determinants and reasons for the non-reporting of adverse drug reactions by pharmacists in the Miyagi and Hokkaido regions of Japan. Adv Pharmacoepidemiol Drug Saf. 2015;4:191. doi:10.4172/2167-1052.1000191.
47.
NadewSSBeyeneKGBezaSW. Adverse drug reaction reporting practice and associated factors among medical doctors in government hospitals in Addis Ababa, Ethiopia. PLoS One. 2020;15(1):e0227712.
48.
HadiMAHelwaniRLongCM. Facilitators and barriers towards adverse drug reaction reporting: Perspective of Malaysian hospital pharmacists. J Pharm Health Serv Res. 2013;4(3):155–8.
49.
LiuJZhouZYangSFengBZhaoJLiuHFactors that affect adverse drug reaction reporting among hospital pharmacists in Western China. Int J Clin Pharm. 2015;37:457–64.
50.
TantiACamilleriMBonannoPVBorgJJ. Medication errors through a national pharmacovigilance database approach: A study for Malta. Int J Risk Saf Med. 2013;25(1):17–27.
51.
PetrinoRRiesgoLGYilmazB. Burnout in emergency medicine professionals after 2 years of the COVID-19 pandemic: A threat to the healthcare system?Eur J Emerg Med. 2022;29(4):279–84.
52.
de KoningREgizAKotechaJCiuculeteACOoiSZYBankoleNDASurvey fatigue during the covid-19 pandemic: An analysis of neurosurgery survey response rates. Front Surg. 2021;8:690680.
